| Financial Year |
March 31 2023 |
| Monetary Funds |
412,309,375.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,987,961.06 |
| Accounts Receivable |
117,838,426.08 |
| Advances to Suppliers |
6,167,949.30 |
| Other Receivables |
48,038,321.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
494,202,273.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,286,679.73 |
| Total Current Assets |
1,187,139,082.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,023,530.50 |
| Fixed Assetes |
945,089,368.62 |
| Under-construction Projects |
51,240,232.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,892,794.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
28,655,544.17 |
| Other Non-Current Assets |
5,007,739.23 |
| Sub-Total of Non-Current Assets |
1,331,794,912.15 |
| Total Assets |
2,518,933,994.33 |
| Short-Term Loans |
170,213,003.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
136,447,646.93 |
| Accounts Payable |
388,641,581.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,985,835.26 |
| Taxes Payable |
7,257,104.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
371,126,073.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,920,059.17 |
| Other Current Liabilities |
23,684,266.43 |
| Sub-Total of Current Liabilities |
1,136,735,557.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,871,278.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,909,486.46 |
| Total Liabilities |
1,166,645,043.91 |
| Paid-In Capital(Or Share Stock) |
926,400,000.00 |
| Capital Surplus |
591,536,265.25 |
| Surplus Reserve |
23,905,976.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-189,673,438.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,352,288,950.42 |
| Owner's Equity（Stockholder's Equity） |
1,352,288,950.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,518,933,994.33 |
